<?xml version="1.0" encoding="UTF-8"?>
<!--Exported from Dataspace Demo Server at https://cds.labkey.com/project/Demo%20Data/BH%20302/begin.view by kristinf on Thu Sep 25 17:44:23 PDT 2014-->
<study archiveVersion="14.21" label="BH 302" timepointType="VISIT" subjectNounSingular="Subject" subjectNounPlural="Subjects" subjectColumnName="SubjectId" investigator="Piehler B" grant="UNJR" species="Human" alternateIdPrefix="" alternateIdDigits="6" defaultTimepointDuration="1" startDate="2002-03-12-08:00" endDate="2013-12-31-08:00" securityType="BASIC_READ" xmlns="http://labkey.org/study/xml">
  <assaySchedule dir="assaySchedule"/>
  <cohorts type="MANUAL" mode="SIMPLE" file="cohorts.xml"/>
  <datasets dir="datasets" file="datasets_manifest.xml">
    <definition file="BH.dataset"/>
  </datasets>
  <comments/>
  <specimens dir="specimens" settings="specimen_settings.xml" file="BH.specimens"/>
  <treatmentData dir="treatmentData"/>
  <visits file="visit_map.xml"/>
  <studyViews dir="views" settings="settings.xml"/>
  <studyDescription rendererType="TEXT_WITH_LINKS">
    <description>BH 302, is the name of an HIV vaccine clinical trial combining two vaccines that failed on their own, vaccinating in Thailand over the course of 24 weeks in October 2003 then testing for HIV until July 2006 [2], publicly releasing efficacy findings in September 2009. The initial report shows that the rate of HIV infection among volunteers who received the experimental vaccine was 31% lower than the rate of HIV infection in volunteers who received the placebo.</description>
  </studyDescription>
  <properties dir="properties"/>
</study>